medtron ltmdt see 15 pct earn growth medtron see 15 pct growth sale earn year end april 30 1988 analyst meet compani year end april 30 1987 earn 73 mln dlrs 515535 dlrs share sale 500 mln dlrs year ago period compani earn 534 mln dlrs 365 dlrs share sale 4028 mln dlrs winston wallin medtron chairman compani improv market share fiscal 1988 cardiac pacemak expand cardiovascular therapeut product line wallin caution analyst quick chang share estim compani medtron heavi sale market expens fiscal 1988 compani intend reinvest earn busi dividend sharehold grow busi reinvest dividend share repurchas wallin see medtron share total worldwid pacemak market increas 42 pct fiscal 1988 40 pct fiscal 1987 worldwid market cardiovascualr therapeut product includ pacemak valv cathet laser valu 25 billion dlrs 1990 doubl 1995 wallin object hold product start build market share beg borrow steal market past medtron pacemak plagu number problem lead product recal regul critic industri cite qualiti problem needless overprescript pacemak knowledg major problem pacemak lead wallin intend reestablish compani qualiti leader industri glen nelson execut vice presid medtron compani intend diversifi intern acquisit compani area medtron expertis drug deliveri system wallin 15 pct earn growth fiscal 1988 includ dilut acquisit hope safeti provis wont major dilut acquisit wallin compani virtual exclus rate respons pacemak fiscal 1988 compani market activitrax singl chamber pacemak vari heartrat respons physic activ siemen ag west german compani develop rate respons pacemak